Trabectedin and immune checkpoint inhibitors: a blissful combination or another failure in soft tissue sarcomas?

被引：0
作者：
Assi, Tarek [1 ]
Le Cesne, Axel [1 ]
机构：
[1] Gustave Roussy Canc Campus, Div Int Patients Care, Villejuif, France
来源：
IMMUNOTHERAPY | 2023年 / 15卷 / 01期
关键词：
cancer immunology; checkpoint inhibitors; immunotherapy; sarcoma; soft tissue; trabectedin; NIVOLUMAB; ANTITUMOR; PHASE-2;
D O I：
10.2217/imt-2022-0157
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：5 / 8
页数：4
相关论文
共 20 条
  • [1] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
    Andtbacka, Robert H. I.
    Kaufman, Howard L.
    Collichio, Frances
    Amatruda, Thomas
    Senzer, Neil
    Chesney, Jason
    Delman, Keith A.
    Spitler, Lynn E.
    Puzanov, Igor
    Agarwala, Sanjiv S.
    Milhem, Mohammed
    Cranmer, Lee
    Curti, Brendan
    Lewis, Karl
    Ross, Merrick
    Guthrie, Troy
    Linette, Gerald P.
    Daniels, Gregory A.
    Harrington, Kevin
    Middleton, Mark R.
    Miller, Wilson H., Jr.
    Zager, Jonathan S.
    Ye, Yining
    Yao, Bin
    Li, Ai
    Doleman, Susan
    VanderWalde, Ari
    Gansert, Jennifer
    Coffin, Robert S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) : 2780 - U98
  • [2] A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma
    Assi, Tarek
    Kattan, Joseph
    El Rassy, Elie
    Honore, Charles
    Dumont, Sarah
    Mir, Olivier
    Le Cesne, Axel
    [J]. CANCER TREATMENT REVIEWS, 2019, 72 : 37 - 44
  • [3] Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy
    Belgiovine, Cristina
    Frapolli, Roberta
    Liguori, Manuela
    Digifico, Elisabeth
    Colombo, Federico Simone
    Meroni, Marina
    Allavena, Paola
    D'Incalci, Maurizio
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (11) : 2677 - 2686
  • [4] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Borghaei, H.
    Paz-Ares, L.
    Horn, L.
    Spigel, D. R.
    Steins, M.
    Ready, N. E.
    Chow, L. Q.
    Vokes, E. E.
    Felip, E.
    Holgado, E.
    Barlesi, F.
    Kohlhaeufl, M.
    Arrieta, O.
    Burgio, M. A.
    Fayette, J.
    Lena, H.
    Poddubskaya, E.
    Gerber, D. E.
    Gettinger, S. N.
    Rudin, C. M.
    Rizvi, N.
    Crino, L.
    Blumenschein, G. R.
    Antonia, S. J.
    Dorange, C.
    Harbison, C. T.
    Finckenstein, F. Graf
    Brahmer, J. R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) : 1627 - 1639
  • [5] Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach
    Chamseddine, Ali N.
    Assi, Tarek
    Mir, Olivier
    Chouaib, Salem
    [J]. PHARMACOLOGY & THERAPEUTICS, 2022, 231
  • [6] A phase 2 study of talimogene laherparepvec, nivolumab, and trabectedin (TNT) in advanced sarcoma.
    Chawla, Neal Shiv
    Kim, Ted
    Sherman, Travis
    Dang, Jonathan
    Chua, Victoria S.
    Moradkhani, Ania
    Bhuiyan, Ishrat
    Krkyan, Nathalie
    Fernando, Mitchel
    Colletti, Emma
    Feske, William
    Zheng, Kitty
    Chow, Warren Allen
    Agulnik, Mark
    Quon, Doris
    Chawla, Sant P.
    Gordon, Erlinda Maria
    Singh, Arun S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Chawla SP., AM SOC CLIN ONCOL, V28, P1199
  • [8] Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
    D'Angelo, Sandra P.
    Mahoney, Michelle R.
    Van Tine, Brian A.
    Atkins, James
    Milhem, Mohammed M.
    Jahagirdar, Balkrishna N.
    Antonescu, Cristina R.
    Horvath, Elise
    Tap, William D.
    Schwartz, Gary K.
    Streicher, Howard
    [J]. LANCET ONCOLOGY, 2018, 19 (03) : 416 - 426
  • [9] Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian Cancer
    Digklia, Antonia
    Coukos, George
    Homicsko, Krisztian
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (09) : 1745 - 1747
  • [10] Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
    Germano, Giovanni
    Frapolli, Roberta
    Belgiovine, Cristina
    Anselmo, Achille
    Pesce, Samantha
    Liguori, Manuela
    Erba, Eugenio
    Uboldi, Sarah
    Zucchetti, Massimo
    Pasqualini, Fabio
    Nebuloni, Manuela
    van Rooijen, Nico
    Mortarini, Roberta
    Beltrame, Luca
    Marchini, Sergio
    Nerini, Ilaria Fuso
    Sanfilippo, Roberta
    Casali, Paolo G.
    Pilotti, Silvana
    Galmarini, Carlos M.
    Anichini, Andrea
    Mantovani, Alberto
    D'Incalci, Maurizio
    Allavena, Paola
    [J]. CANCER CELL, 2013, 23 (02) : 249 - 262
12